Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionAmeriprise Financial Inc
Latest Disclosed Ownership1,579,793 shares
Latest Disclosed Value $ 153,635,129
Ameriprise Financial Inc reports 23.19% decrease in ownership of RVMD / Revolution Medicines, Inc.

On May 15, 2026 - Ameriprise Financial Inc filed a 13F-HR form disclosing ownership of 1,579,793 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $153,635,129 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,056,857 shares of Revolution Medicines, Inc.. This represents a change in shares of -23.19% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 1,579,793 -477,064 -23.19 153,635 -6.22 0.0066
2026-02-17 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 2,056,857 832,098 67.94 163,829 186.43 0.0068
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 1,224,759 -119,701 -8.90 57,196 15.64 0.0024
2025-08-14 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 1,344,460 -146,198 -9.81 49,463 -6.16 0.0122
2025-05-14 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 1,490,658 -136,190 -8.37 52,710 -25.93 0.0142
2025-02-14 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 1,626,848 141,426 9.52 71,158 5.63 0.0183
2024-11-14 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 1,485,422 13,132 0.89 67,364 17.89 0.0173
2024-08-14 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 1,472,290 -222,211 -13.11 57,140 4.63 0.0155
2024-05-15 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 1,694,501 71,480 4.40 54,614 17.33 0.0150
2024-02-14 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 1,623,021 411,165 33.93 46,548 38.77 0.0139
2023-11-14 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 1,211,856 -11,869 -0.97 33,544 2.47 0.0110
2023-08-14 2023-06-30 13F REVOLUTION MEDICINES COM 76155X100 1,223,725 99,767 8.88 32,735 34.46 0.0103
2023-05-22 2023-03-31 13F/A-1 REVOLUTION MEDICINES COM 76155X100 1,123,958 423,035 60.35 24,345 45.82 0.0080
2023-05-15 2023-03-31 13F REVANCE THERAPEUTICS COM 76155X100 1,123,958 423,035 24,345 0.0015
2023-02-14 2022-12-31 13F REVOLUTION MEDICINES COM 76155X100 700,923 -292,140 -29.42 16,694 -14.68 0.0057
2022-11-14 2022-09-30 13F REVOLUTION MEDICINES COM 76155X100 993,063 -8,245 -0.82 19,566 0.34 0.0072
2022-08-15 2022-06-30 13F REVOLUTION MEDICINES COM 76155X100 1,001,308 30,794 3.17 19,500 -21.22 0.0068
2022-05-16 2022-03-31 13F REVOLUTION MEDICINES COM 76155X100 970,514 9,218 0.96 24,754 2.31 0.0073
2022-02-14 2021-12-31 13F REVOLUTION MEDICINES COM 76155X100 961,296 2,069 0.22 24,196 -8.32 0.0067
2021-11-15 2021-09-30 13F REVOLUTION MEDICINES COM 76155X100 959,227 21,742 2.32 26,393 -11.25 0.0084
2021-08-16 2021-06-30 13F REVOLUTION MEDICINES COM 76155X100 937,485 517,478 123.21 29,740 54.34 0.0092
2021-05-17 2021-03-31 13F REVOLUTION MEDICINES COM 76155X100 420,007 148,682 54.80 19,269 79.35 0.0064
2021-02-12 2020-12-31 13F REVOLUTION MEDICINES COM 76155X100 271,325 221,086 440.07 10,744 513.94 0.0038
2020-11-16 2020-09-30 13F REVOLUTION MEDICINES COM 76155X100 50,239 5,795 13.04 1,750 24.64 0.0007
2020-08-14 2020-06-30 13F REVOLUTION MEDICINES COM 76155X100 44,444 -19,091 -30.05 1,404 0.86 0.0006
2020-05-15 2020-03-31 13F REVOLUTION MEDICINES COM 76155X100 63,535 63,535 1,392 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.